3-(Chloromethyl)-5-methoxypyridine hydrochloride

Catalog No.: 
ACTGKN295
CAS No.: 
1801422-13-8
Molecular Formula: 
C7H9Cl2NO
Molecular Weight: 
194.06
3-(Chloromethyl)-5-methoxypyridine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$81.00In stockInquiry
250mg95%$100.00In stockInquiry
1g95%$314.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Chloromethyl)-5-methoxypyridine hydrochloride
IUPAC Name3-(chloromethyl)-5-methoxypyridine hydrochloride
MDL No.MFCD28506091
Molecular FormulaC7H9Cl2NO
Molecular Weight194.06
SMILESCOC1=CN=CC(CCl)=C1.[H]Cl
InChI KeyJAAVRIRETDIITP-UHFFFAOYSA-N
Synonym3-(chloromethyl)-5-methoxypyridine hydrochloride
CAS No.1801422-13-8
PubChem CID118798967

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H314
Precautionary Statement(s)
P264-P271-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACTGKN295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPDHY546 route compound structure diagram
    ACPDHY546937202-11-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGKN295 route product structure diagram
    ACTGKN2951801422-13-8In Stock
Inquiry

2. ACTGKN295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGKN295 route product structure diagram
    ACTGKN2951801422-13-8In Stock
Inquiry

3. ACTGKN295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTGKN295 route product structure diagram
    ACTGKN2951801422-13-8In Stock
Inquiry

Comments (0)